Matt Phipps
Stock Analyst at William Blair
(3.81)
# 1,977
Out of 4,993 analysts
614
Total ratings
46.6%
Success rate
3.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matt Phipps
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintained: Buy | n/a | $393.16 | - | 43 | Sep 22, 2026 | |
| NAMS NewAmsterdam Pharma Company | Reiterated: Buy | n/a | $22.58 | - | 16 | Sep 18, 2026 | |
| ZNTL Zentalis Pharmaceuticals | Initiated Coverage: Buy | n/a | $3.03 | - | 1 | Sep 15, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | n/a | $21.35 | - | 25 | Sep 14, 2026 | |
| AUTL Autolus Therapeutics | Reiterated: Buy | n/a | $1.94 | - | 43 | Sep 9, 2026 | |
| EVMN Evommune | Reiterated: Hold | n/a | $9.45 | - | 18 | Sep 9, 2026 | |
| UPB Upstream Bio | Reiterated: Buy | n/a | $5.37 | - | 23 | Sep 8, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | n/a | $13.64 | - | 15 | Sep 3, 2026 | |
| ARGX argenx SE | Reiterated: Buy | n/a | $988.20 | - | 15 | Sep 2, 2026 | |
| TENX Tenax Therapeutics | Reiterated: Hold | n/a | $1.88 | - | 20 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $124.65 | - | 49 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $62.62 | - | 61 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.01 | - | 20 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $34.69 | - | 26 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.50 | - | 2 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.74 | - | 6 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.82 | - | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.3746 | - | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $121.00 | - | 14 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.03 | - | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.81 | - | 9 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.48 | - | 11 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $264.48 | - | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.6027 | - | 18 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $205.49 | - | 1 | Jan 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $117 | $44.90 | +160.04% | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $96.47 | n/a | 1 | Sep 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.33 | n/a | 19 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.25 | n/a | 8 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $510.72 | n/a | 1 | Jun 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $172.94 | n/a | 1 | Jun 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.32 | n/a | 11 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7738 | n/a | 5 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1.2 | $10.83 | n/a | 1 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7902 | n/a | 13 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $153.41 | n/a | 19 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.38 | n/a | 14 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0003 | n/a | 11 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.20 | n/a | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $219.07 | n/a | 26 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $66.84 | n/a | 1 | Jun 11, 2021 |
Amgen
Sep 22, 2026
Maintained: Buy
Price Target: n/a
Current: $393.16
Upside: -
NewAmsterdam Pharma Company
Sep 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.58
Upside: -
Zentalis Pharmaceuticals
Sep 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $3.03
Upside: -
Cullinan Therapeutics
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $21.35
Upside: -
Autolus Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.94
Upside: -
Evommune
Sep 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $9.45
Upside: -
Upstream Bio
Sep 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.37
Upside: -
Climb Bio
Sep 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.64
Upside: -
argenx SE
Sep 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $988.20
Upside: -
Tenax Therapeutics
Aug 31, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.88
Upside: -
Aug 19, 2026
Reiterated: Hold
Price Target: n/a
Current: $124.65
Upside: -
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $62.62
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $17.01
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $34.69
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.50
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $16.74
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.82
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.3746
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $121.00
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $25.03
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.81
Upside: -
Aug 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $11.48
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $264.48
Upside: -
Jun 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.6027
Upside: -
Jan 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $205.49
Upside: -
Oct 11, 2025
Reiterated: Buy
Price Target: $117
Current: $44.90
Upside: +160.04%
Sep 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $96.47
Upside: n/a
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $8.33
Upside: n/a
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $12.25
Upside: n/a
Jun 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $510.72
Upside: n/a
Jun 7, 2025
Reiterated: Hold
Price Target: n/a
Current: $172.94
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $1.32
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $0.7738
Upside: n/a
Mar 29, 2025
Initiated Coverage: Buy
Price Target: $1.2
Current: $10.83
Upside: n/a
Dec 29, 2022
Rated: Hold
Price Target: n/a
Current: $0.7902
Upside: n/a
Jan 3, 2022
Reiterated: Buy
Price Target: n/a
Current: $153.41
Upside: n/a
Dec 7, 2021
Reiterated: Buy
Price Target: n/a
Current: $9.38
Upside: n/a
Dec 7, 2021
Reiterated: Hold
Price Target: n/a
Current: $0.0003
Upside: n/a
Nov 19, 2021
Reiterated: Buy
Price Target: n/a
Current: $1.20
Upside: n/a
Jul 23, 2021
Rated: Buy
Price Target: n/a
Current: $219.07
Upside: n/a
Jun 11, 2021
Reiterated: Buy
Price Target: n/a
Current: $66.84
Upside: n/a